Pressure Bio Q1 Revenues Increase 21 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that its first-quarter revenues jumped 21 percent year over year as its product revenues increased 34 percent.

The South Easton, Mass.-based firm said that it recorded $370,737 in total revenues for the three months ended March 31, compared to $305,661 in the first quarter of 2012. Revenues from its Pressure Cycling Technology products, services, and other led the revenue growth in the quarter, reaching $221,569, up from $164,772 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.